United States · Bill · HR
H.R. 3012 (114th)
Right to Try Act of 2015
Introduced
9 July 2015
Last action
—
Status
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Sponsors
—
Subjects
Discovery layer
Source updated
12 August 2025
Summary
Right to Try Act of 2015 Bars the federal government from prohibiting or restricting the production, manufacture, distribution, prescribing, dispensing, possession, or use of an experimental drug, biological product, or device that is: (1) intended to treat a patient who has been diagnosed with a terminal illness; and (2) authorized by, and in accordance with, state law. Defines an "experimental drug, biological product, or device" as one that: (1) has successfully completed a phase 1 clinical investigation; (2) remains under investigation in a clinical trial approved by the Food and Drug Administration; and (3) is not approved, licensed, or cleared for commercial distribution under the Federal Food, Drug, or Cosmetic Act or the Public Health Service Act.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 9 July 2015
Introduced in House (PDF)
Introduced in House · EN · 9 July 2015
Introduced in House
summary · EN · 9 July 2015
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/114th-congress/house-bill/3012
- Open data entity: https://api.congress.gov/v3/bill/114/hr/3012